Ott1 (Rbm15) is essential for placental vascular branching morphogenesis and embryonic development of the heart and spleen

Molecular and Cellular Biology

Volumn 29, Issue 2, 2009, Pages 333-341

  Raffel, Glen D ^a,f   Chu, Gerald C ^b   Jesneck, Jonathan L ^b,c   Cullen, Dana E ^a   Bronson, Roderick T ^a   Bernard, Olivier A ^d,e   Gilliland, D Gary ^a,g  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d INSERM   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL COMPARTMENTALIZATION; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; CRE GENE; DROSOPHILA MELANOGASTER; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GENE; GENE DELETION; GENE EXPRESSION; GENE REPRESSION; HEART DEVELOPMENT; LEUKEMOGENESIS; MALE; MOLECULAR RECOGNITION; MORPHOGENESIS; MOUSE; MULTIGENE FAMILY; NONHUMAN; NOTOCHORD; NUCLEOTIDE SEQUENCE; OTT1 GENE; PLACENTA; PLACENTA INSUFFICIENCY; PRIORITY JOURNAL; REGULATORY MECHANISM; SPEN GENE; SPLEEN DEVELOPMENT; SYNCYTIOTROPHOBLAST; TRANSCRIPTION INITIATION; TRANSGENE; TROPHOBLAST;

ANIMALS; CELL HYPOXIA; DROSOPHILA PROTEINS; EMBRYO, MAMMALIAN; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART; IN SITU HYBRIDIZATION; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MORPHOGENESIS; ORGANOGENESIS; PLACENTA; PREGNANCY; RNA-BINDING PROTEINS; SPLEEN; TROPHOBLASTS; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA; DROSOPHILA MELANOGASTER; MURINAE; MUS;

EID: 58249124525     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00370-08     Document Type: Article

References (67)

1. Adelman, D. M., M. Gertsenstein, A. Nagy, M. C. Simon, and E. Maltepe. 2000. Placental cell fates are regulated in vivo by HIF-mediated hypoxia responses. Genes Dev. 14:3191-3203.
2. Anson-Cartwright, L., K. Dawson, D. Holmyard, S. J. Fisher, R. A. Lazzarini, and J. C. Cross. 2000. The glial cells missing-1 protein is essential for branching morphogenesis in the chorioallantoic placenta. Nat. Genet. 25: 311-314.
3. Ashburner, M., C. A. Ball, J. A. Blake, D. Botstein, H. Butler, J. M. Cherry, A. P. Davis, K. Dolinski, S. S. Dwight, J. T. Eppig, M. A. Harris, D. P. Hill, L. Issel-Tarver, A. Kasarskis, S. Lewis, J. C. Matese, J. E. Richardson, M. Ringwald, G. M. Rubin, G. Sherlock, et al. 2000. Gene Ontology: tool for the unification of biology. Nat. Genet. 25:25-29.
4. Bamforth, S. D., J. Braganca, J. J. Eloranta, J. N. Murdoch, F. I. Marques, K. R. Kranc, H. Farza, D. J. Henderson, H. C. Hurst, and S. Bhattacharya. 2001. Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator. Nat. Genet. 29:469-474.
5. Bhattacharya, S., C. L. Michels, M. K. Leung, Z. P. Arany, A. L. Kung, and D. M. Livingston. 1999. Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes Dev. 13:64-75.
6. Brendolan, A., E. Ferretti, V. Salsi, K. Moses, S. Quaggin, F. Blasi, M. L. Cleary, and L. Selleri. 2005. A Pbx1-dependent genetic and transcriptional network regulates spleen ontogeny. Development 132:3113-3126.
7. Calzonetti, T., L. Stevenson, and J. Rossant. 1995. A novel regulatory region is required for trophoblast-specific transcription in transgenic mice. Dev. Biol. 171:615-626.
8. Carmeliet, P., V. Ferreira, G. Breier, S. Pollefeyt, L. Kieckens, M. Gertsen-stein, M. Fahrig, A. Vandenhoeck, K. Harpal, C. Eberhardt, C. Declercq, J. Pawling, L. Moons, D. Collen, W. Risau, and A. Nagy. 1996. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-439.
9. Chawengsaksophak, K., R. James, V. E. Hammond, F. Kontgen, and F. Beck. 1997. Homeosis and intestinal tumours in Cdx2 mutant mice. Nature 386: 84-87.
10. Clark, K. L., K. E. Yutzey, and D. W. Benson. 2006. Transcription factors and congenital heart defects. Annu. Rev. Physiol. 68:97-121.
11. Cloud, J. E., C. Rogers, T. L. Reza, U. Ziebold, J. R. Stone, M. H. Picard, A. M. Caron, R. T. Bronson, and J. A. Lees. 2002. Mutant mouse models reveal the relative roles of E2F1 and E2F3 in vivo. Mol. Cell. Biol. 22:2663-2672.
12. Colston, J. T., W. H. Boylston, M. D. Feldman, C. P. Jenkinson, S. D. de la Rosa, A. Barton, R. J. Trevino, G. L. Freeman, and B. Chandrasekar. 2007. Interleukin-18 knockout mice display maladaptive cardiac hypertrophy in response to pressure overload. Biochem. Biophys. Res. Commun. 354:552-558.
13. Conway, S. J., A. Kruzynska-Frejtag, P. L. Kneer, M. Machnicki, and S. V. Koushik. 2003. What cardiovascular defect does my prenatal mouse mutant have, and why? Genesis 35:1-21.
14. Cowden Dahl, K. D., B. H. Fryer, F. A. Mack, V. Compernolle, E. Maltepe, D. M. Adelman, P. Carmeliet, and M. C. Simon. 2005. Hypoxia-inducible factors 1α and 2α regulate trophoblast differentiation. Mol. Cell. Biol. 25: 10479-10491.
15. Cross, J. C., M. Hemberger, Y. Lu, T. Nozaki, K. Whiteley, M. Masutani, and S. L. Adamson. 2002. Trophoblast functions, angiogenesis and remodeling of the maternal vasculature in the placenta. Mol. Cell. Endocrinol. 187:207-212.
16. Cross, J. C., H. Nakano, D. R. Natale, D. G. Simmons, and E. D. Watson. 2006. Branching morphogenesis during development of placental villi. Differentiation 74:393-401.
17. Dumont, D. J., G. H. Fong, M. C. Puri, G. Gradwohl, K. Alitalo, and M. L. Breitman. 1995. Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev. Dyn. 203:80-92.
18. Ebelt, H., N. Hufnagel, P. Neuhaus, H. Neuhaus, P. Gajawada, A. Simm, U. Muller-Werdan, K. Werdan, and T. Braun. 2005. Divergent siblings: E2F2 and E2F4 but not E2F1 and E2F3 induce DNA synthesis in cardiomyocytes without activation of apoptosis. Circ. Res. 96:509-517.
19. Ferrara, N., K. Carver-Moore, H. Chen, M. Dowd, L. Lu, K. S. O'Shea, L. Powell-Braxton, K. J. Hillan, and M. W. Moore. 1996. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-442.
20. Fischer, A., N. Schumacher, M. Maier, M. Sendtner, and M. Gessler. 2004. The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev. 18:901-911.
21. Gentleman, R. C., V. J. Carey, D. M. Bates, B. Bolstad, M. Dettling, S. Dudoit, B. Ellis, L. Gautier, Y. Ge, J. Gentry, K. Hornik, T. Hothorn, W. Huber, S. Iacus, R. Irizarry, F. Leisch, C. Li, M. Maechler, A. J. Rossini, G. Sawitzki, C. Smith, G. Smyth, L. Tierney, J. Y. Yang, and J. Zhang. 2004. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5:R80.
22. Gerety, S. S., and D. J. Anderson. 2002. Cardiovascular ephrinB2 function is essential for embryonic angiogenesis. Development 129:1397-1410.
23. Gong, L., M. Liu, J. Jen, and E. T. Yeh. 2000. GNB1L, a gene deleted in the critical region for DiGeorge syndrome on 22q11, encodes a G-protein beta-subunit-like polypeptide. Biochim. Biophys. Acta 1494:185-188.
24. Hayashi, S., P. Lewis, L. Pevny, and A. P. McMahon. 2002. Efficient gene modulation in mouse epiblast using a Sox2Cre transgenic mouse strain. Mech. Dev. 119(Suppl. 1):S97-S101.
25. Herzer, U., A. Crocoll, D. Barton, N. Howells, and C. Englert. 1999. The Wilms tumor suppressor gene wt1 is required for development of the spleen. Curr. Biol. 9:837-840.
26. High, F. A., and J. A. Epstein. 2008. The multifaceted role of Notch in cardiac development and disease. Nat. Rev. Genet. 9:49-61.
27. Hiriart, E., H. Gruffat, M. Buisson, I. Mikaelian, S. Keppler, P. Meresse, T. Mercher, O. A. Bernard, A. Sergeant, and E. Manet. 2005. Interaction of the Epstein-Barr virus mRNA export factor EB2 with human Spen proteins SHARP, OTT1, and a novel member of the family, OTT3, links Spen proteins with splicing regulation and mRNA export. J. Biol. Chem. 280: 36935-36945.
28. Irizarry, R. A., B. Hobbs, F. Collin, Y. D. Beazer-Barclay, K. J. Antonellis, U. Scherf, and T. P. Speed. 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-264.
29. Jones, R. L., L. A. Salamonsen, and J. K. Findlay. 2002. Potential roles for endometrial inhibins, activins and follistatin during human embryo implantation and early pregnancy. Trends Endocrinol. Metab. 13:144-150.
30. Kokubo, H., S. Miyagawa-Tomita, M. Nakazawa, Y. Saga, and R. L. Johnson. 2005. Mouse hesr1 and hesr2 genes are redundantly required to mediate Notch signaling in the developing cardiovascular system. Dev. Biol. 278:301-309.
31. Kosaki, R., M. Gebbia, K. Kosaki, M. Lewin, P. Bowers, J. A. Towbin, and B. Casey. 1999. Left-right axis malformations associated with mutations in ACVR2B, the gene for human activin receptor type IIB. Am. J. Med. Genet. 82:70-76.
32. Kuang, B., S. C. Wu, Y. Shin, L. Luo, and P. Kolodziej. 2000. Split ends encodes large nuclear proteins that regulate neuronal cell fate and axon extension in the Drosophila embryo. Development 127:1517-1529.
33. Kuroda, K., H. Han, S. Tani, K. Tanigaki, T. Tun, T. Furukawa, Y. Tanigu-chi, H. Kurooka, Y. Hamada, S. Toyokuni, and T. Honjo. 2003. Regulation of marginal zone B cell development by MINT, a suppressor of Notch/RBP-J. signaling pathway. Immunity 18:301-312.
34. Leonard, M. O., D. C. Cottell, C. Godson, H. R. Brady, and C. T. Taylor. 2003. The role of HIF-1 alpha in transcriptional regulation of the proximal tubular epithelial cell response to hypoxia. J. Biol. Chem. 278:40296-40304.
35. Li, L., I. D. Krantz, Y. Deng, A. Genin, A. B. Banta, C. C. Collins, M. Qi, B. J. Trask, W. L. Kuo, J. Cochran, T. Costa, M. E. Pierpont, E. B. Rand, D. A. Piccoli, L. Hood, and N. B. Spinner. 1997. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat. Genet. 16:243-251.
36. Lindsay, E. A., F. Vitelli, H. Su, M. Morishima, T. Huynh, T. Pramparo, V. Jurecic, G. Ogunrinu, H. F. Sutherland, P. J. Scambler, A. Bradley, and A. Baldini. 2001. Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 410:97-101.
37. Lindtner, S., A. S. Zolotukhin, H. Uranishi, J. Bear, V. Kulkarni, S. Smu-levitch, M. Samiotaki, G. Panayotou, B. K. Felber, and G. N. Pavlakis. 2006. RNA-binding motif protein 15 binds to the RNA transport element RTE and provides a direct link to the NXF1 export pathway. J. Biol. Chem. 281:36915-36928.
38. Ma, X., M. J. Renda, L. Wang, E. C. Cheng, C. Niu, S. W. Morris, A. S. Chi, and D. S. Krause. 2007. Rbm15 modulates Notch-induced transcriptional activation and affects myeloid differentiation. Mol. Cell. Biol. 27:3056-3064.
39. Ma, Z., S. W. Morris, V. Valentine, M. Li, J. A. Herbrick, X. Cui, D. Bouman, Y. Li, P. K. Mehta, D. Nizetic, Y. Kaneko, G. C. Chan, L. C. Chan, J. Squire, S. W. Scherer, and J. K. Hitzler. 2001. Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia. Nat. Genet. 28:220-221.
40. Mallat, Z., C. Heymes, A. Corbaz, D. Logeart, S. Alouani, A. Cohen-Solal, T. Seidler, G. Hasenfuss, Y. Chvatchko, A. M. Shah, and A. Tedgui. 2004. Evidence for altered interleukin 18 (IL)-18 pathway in human heart failure. FASEB J. 18:1752-1754.
41. Mercher, T., M. B. Coniat, R. Monni, M. Mauchauffe, F. N. Khac, L. Gressin, F. Mugneret, T. Leblanc, N. Dastugue, R. Berger, and O. A. Bernard. 2001. Involvement of a human gene related to the Drosophila spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemia. Proc. Natl. Acad. Sci. USA 98:5776-5779.
42. Merscher, S., B. Funke, J. A. Epstein, J. Heyer, A. Puech, M. M. Lu, R. J. Xavier, M. B. Demay, R. G. Russell, S. Factor, K. Tokooya, B. S. Jore, M. Lopez, R. K. Pandita, M. Lia, D. Carrion, H. Xu, H. Schorle, J. B. Kobler, P. Scambler, A. Wynshaw-Boris, A. I. Skoultchi, B. E. Morrow, and R. Kucherlapati. 2001. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104:619-629.
43. Newberry, E. P., T. Latifi, and D. A. Towler. 1999. The RRM domain of MINT, a novel Msx2 binding protein, recognizes and regulates the rat osteocalcin promoter. Biochemistry 38:10678-10690.
44. Nguyen, B. C., K. Lefort, A. Mandinova, D. Antonini, V. Devgan, G. Delia Gatta, M. I. Koster, Z. Zhang, J. Wang, A. Tommasi di Vignano, J. Kita-jewski, G. Chiorino, D. R. Roop, C. Missero, and G. P. Dotto. 2006. Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation. Genes Dev. 20:1028-1042.
45. Oda, T., A. G. Elkahloun, P. S. Meltzer, and S. C. Chandrasekharappa. 1997. Identification and cloning of the human homolog (JAG1) of the rat Jagged1 gene from the Alagille syndrome critical region at 20p12. Genomics 43:376-379.
46. Oh, S. P., and E. Li. 2002. Gene-dosage-sensitive genetic interactions between inversus viscerum (iv), nodal, and activin type IIB receptor (ActRIIB) genes in asymmetrical patterning of the visceral organs along the left-right axis. Dev. Dyn. 224:279-290.
47. Oh, S. P., and E. Li. 1997. The signaling pathway mediated by the type IIB activin receptor controls axial patterning and lateral asymmetry in the mouse. Genes Dev. 11:1812-1826.
48. Raffel, G. D., T. Mercher, H. Shigematsu, I. R. Williams, D. E. Cullen, K. Akashi, O. A. Bernard, and D. G. Gilliland. 2007. Ott1(Rbm15) has pleio-tropic roles in hematopoietic development. Proc. Natl. Acad. Sci. USA 104:6001-6006.
49. Rebay, I., F. Chen, F. Hsiao, P. A. Kolodziej, B. H. Kuang, T. Laverty, C. Suh, M. Voas, A. Williams, and G. M. Rubin. 2000. A genetic screen for novel components of the Ras/mitogen-activated protein kinase signaling pathway that interact with the yan gene of Drosophila identifies split ends, a new RNA recognition motif-containing protein. Genetics 154:695-712.
50. Reich, M., T. Liefeld, J. Gould, J. Lerner, P. Tamayo, and J. P. Mesirov. 2006. GenePattern 2.0. Nat. Genet. 38:500-501.
51. Reynolds, L. P., P. P. Borowicz, K. A. Vonnahme, M. L. Johnson, A. T. Grazul-Bilska, J. M. Wallace, J. S. Caton, and D. A. Redmer. 2005. Animal models of placental angiogenesis. Placenta 26:689-708.
52. Rinkenberger, J. L., J. C. Cross, and Z. Werb. 1997. Molecular genetics of implantation in the mouse. Dev. Genet. 21:6-20.
53. Rossant, J., and J. C. Cross. 2001. Placental development: lessons from mouse mutants. Nat. Rev. Genet. 2:538-548.
54. Sapin, V., P. Dolle, C. Hindelang, P. Kastner, and P. Chambon. 1997. Defects of the chorioallantoic placenta in mouse RXRalpha null fetuses. Dev. Biol. 191:29-41.
55. Schreiber, M., Z. Q. Wang, W. Jochum, I. Fetka, C. Elliott, and E. F. Wagner. 2000. Placental vascularisation requires the AP-1 component fra1. Development 127:4937-1948.
56. Selleri, L., M. J. Depew, Y. Jacobs, S. K. Chanda, K. Y. Tsang, K. S. Cheah, J. L. Rubenstein, S. O'Gorman, and M. L. Cleary. 2001. Requirement for Pbx1 in skeletal patterning and programming chondrocyte proliferation and differentiation. Development 128:3543-3557.
57. Semenza, G. L. 2001. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol. Med. 7:345-350.
58. Semenza, G. L., F. Agani, N. Iyer, L. Kotch, E. Laughner, S. Leung, and A. Yu. 1999. Regulation of cardiovascular development and physiology by hypoxia-inducible factor 1. Ann. N. Y. Acad. Sci. 874:262-268.
59. Sock, E., S. D. Rettig, J. Enderich, M. R. Bosl, E. R. Tamm, and M. Wegner. 2004. Gene targeting reveals a widespread role for the high-mobility-group transcription factor Sox11 in tissue remodeling. Mol. Cell. Biol. 24:6635-6644.
60. Steingrimsson, E., L. Tessarollo, S. W. Reid, N. A. Jenkins, and N. G. Copeland. 1998. The bHLH-Zip transcription factor Tfeb is essential for placental vascularization. Development 125:4607-4616.
61. Subramanian, A., P. Tamayo, V. K. Mootha, S. Mukherjee, B. L. Ebert, M. A. Gillette, A. Paulovich, S. L. Pomeroy, T. R. Golub, E. S. Lander, and J. P. Mesirov. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102:15545-15550.
62. Tanaka, H., K. Nagaike, N. Takeda, H. Itoh, K. Kohama, T. Fukushima, S. Miyata, S. Uchiyama, S. Uchinokura, T. Shimomura, K. Miyazawa, N. Kita-mura, G. Yamada, and H. Kataoka. 2005. Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta. Mol. Cell. Biol. 25:5687-5698.
63. Tanaka, M., M. Gertsenstein, J. Rossant, and A. Nagy. 1997. Mash2 acts cell autonomously in mouse spongiotrophoblast development. Dev. Biol. 190: 55-65.
64. Vuorela, P., E. Hatva, A. Lymboussaki, A. Kaipainen, V. Joukov, M. G. Persico, K. Alitalo, and E. Halmesmaki. 1997. Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol. Reprod. 56:489-494.
65. Weninger, W. J., K. Lopes Floro, M. B. Bennett, S. L. Withington, J. I. Preis, J. P. Barbera, T. J. Mohun, and S. L. Dunwoodie. 2005. Cited2 is required both for heart morphogenesis and establishment of the left-right axis in mouse development. Development 132:1337-1348.
66. Wiellette, E. L., K. W. Harding, K. A. Mace, M. R. Ronshaugen, F. Y. Wang, and W. McGinnis. 1999. spen encodes an RNP motif protein that interacts with Hox pathways to repress the development of head-like sclerites in the Drosophila trunk. Development 126:5373-5385.
67. Withington, S. L., A. N. Scott, D. N. Saunders, K. Lopes Floro, J. I. Preis, J. Michalicek, K. Maclean, D. B. Sparrow, J. P. Barbera, and S. L. Dunwoodie. 2006. Loss of Cited2 affects trophoblast formation and vascularization of the mouse placenta. Dev. Biol. 294:67-82.